phentermine (CTS)

Razin is a brand name for **phentermine**, a sympathomimetic amine anorectic used as a short-term adjunct in the management of exogenous obesity. Developed and marketed by the Israeli pharmaceutical company **CTS**, Razin is indicated for patients with an initial body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia). The drug functions as an appetite suppressant by stimulating the release of norepinephrine in the hypothalamus, which reduces the sensation of hunger. It is chemically related to amphetamine but is primarily used for its weight-loss properties rather than central nervous system stimulation. Razin is typically administered orally in capsule form as part of a comprehensive weight reduction program that includes exercise and caloric restriction.

Brand names

RazinAdipex-PLomairaDuromineSuprenza

Other names

phentermine hydrochloridephenyl-tertiary-butylamine